TG and metabolic dysfunction-associated steatotic liver disease: As shown in Table 5, the 5 chosen pathways included insulin resistance (degree = 8), nonalcoholic fatty liver disease (degree = 8), pathways in cancer (degree = 8), AMPK signaling pathway (degree = 7), and thyroid hormone signaling pathway (degree = 7).